SCHEDULE: Novo Holdings Exits Galecto, Sells All Shares

Novo Holdings A/S has fully divested its stake in Galecto, Inc., ceasing to be a beneficial owner of more than five percent of the common stock.

Summary

• Novo Holdings A/S, a Danish corporation wholly owned by the Novo Nordisk Foundation, no longer beneficially owns any securities of Galecto, Inc.
• On October 7, 2025, Novo Holdings A/S sold all its remaining shares of Galecto, Inc. Common Stock in open market transactions.
• The total shares sold on this date amounted to 86,579 shares across various price ranges.
• Weighted-average prices for these sales ranged from $17.02 to $21.83 per share.
• Novo Holdings A/S ceased to be a beneficial owner of more than five percent of Galecto's Common Stock on October 7, 2025.

Sentiment

Score: 3

Explanation: The complete divestment by a major institutional investor like Novo Holdings A/S is a significant negative signal for Galecto, Inc., indicating a loss of confidence or a strategic shift by the investor. This could put downward pressure on the stock price and investor sentiment.

Negatives

• Novo Holdings A/S, a significant institutional investor, has completely divested its entire stake in Galecto, Inc.
• The cessation of beneficial ownership by a major shareholder could signal a lack of confidence in Galecto's future prospects.

Risks

• Loss of a significant institutional investor may negatively impact investor confidence and the company's share price.
• Reduced institutional ownership could lead to decreased liquidity in Galecto's common stock.

Future Outlook

The filing does not provide any forward-looking statements or guidance from Galecto, Inc. or Novo Holdings A/S regarding Galecto's future operations or financial performance.

Industry Context

This divestment by Novo Holdings A/S, a significant life sciences investor, could be interpreted by the market as a re-evaluation of Galecto's position within the biotechnology or pharmaceutical industry, potentially influencing other institutional investors' perceptions.

Stakeholder Impact

• Shareholders: Existing shareholders of Galecto, Inc. may experience decreased share price and reduced investor confidence due to the exit of a major institutional holder.
• Potential Investors: May view the complete divestment by Novo Holdings A/S as a negative indicator, potentially deterring new investment.

Key Dates

Recommendation

The complete divestment by a major institutional investor like Novo Holdings A/S typically signals a lack of confidence in the company's future prospects or a strategic re-allocation of capital away from the issuer. This event is a strong negative indicator for Galecto, Inc., suggesting potential downward pressure on the stock price and warranting a 'sell' recommendation for investors holding the stock, or caution for potential buyers.

Keywords

Galecto Inc., Novo Holdings A/S, Divestment, Share Sale, Beneficial Ownership, SEC Filing, Schedule 13D/A, Institutional Investor, Common Stock